Presentation is loading. Please wait.

Presentation is loading. Please wait.

Early-onset monocyte–B–natural killer–dendritic cells’ deficiency successfully treated with hematopoietic stem cell transplantation  Caterina Cancrini,

Published byJoseph Shields Modified over 6 years ago

Similar presentations

Presentation on theme: "Early-onset monocyte–B–natural killer–dendritic cells’ deficiency successfully treated with hematopoietic stem cell transplantation  Caterina Cancrini,"— Presentation transcript:

1 Early-onset monocyte–B–natural killer–dendritic cells’ deficiency successfully treated with hematopoietic stem cell transplantation  Caterina Cancrini, MD, PhD, Alessia Scarselli, MD, Samantha Scaramuzza, BSc, PhD, Maria Chiriaco, BSc, PhD, Silvia Di Cesare, BSc, Gigliola Di Matteo, BSc, PhD, Maria Luisa Romiti, BSc, PhD, Paolo Palma, MD, PhD, Lidia De Felice, BSc, Giuseppe Palumbo, MD, PhD, Rita Maria Pinto, MD, Rita De Vito, MD, Luigi Racioppi, MD, PhD, Susanna Livadiotti, MD, Alain Fischer, MD, PhD, Paolo Rossi, MD, PhD, Maurizio Caniglia, MD, Alessandro Aiuti, MD, PhD  Journal of Allergy and Clinical Immunology  Volume 128, Issue 4, Pages e1 (October 2011) DOI: /j.jaci Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2 Fig 1 Immune phenotype and functional assays of PB and BM. A, Flow cytometry of myeloid and plasmacytoid dendritic cells in the patient’s PB before and after (1 year) HSCT as compared with a healthy donor (HD). Gate A is drawn in order to exclude granulocytes, CD19+ B cells, and monocytes (CD14+). B, BM morphology and clonogenic assays (with SCF, GM-CSF, IL-3, and EPO). Normal values of colonies/100,000 mononuclear BM cells: CFU-GM: 155 ± 105, BFU-E: 159 ± 73, CFU-GEMM: 38 ± 23. C, In vitro BM CD34+ cell differentiation in B and NK cells with stromal cells and cytokines (IL-2, IL-7, SCF, IL-15, TPO, FLT3 ligand). Graphs show representative wells containing differentiated B, NK, or myeloid cells after 3 weeks of culture. The table shows the proportion of wells scoring positive for the specific marker. D, In vitro proliferation responses of BM CD34+ cells to different cytokines that are measured by thymidine incorporation. Pt, Patient. Journal of Allergy and Clinical Immunology  , e1DOI: ( /j.jaci ) Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3 Fig E1 Flow cytometry of BM mononuclear cells for the expression of CD19, CD117 (c-kit), CD127 (IL7-R), and CXCR4 on CD34+ cells before and after bone marrow transplantation (BMT) in comparison to a healthy donor. n.d., Not done. Journal of Allergy and Clinical Immunology  , e1DOI: ( /j.jaci ) Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Download ppt "Early-onset monocyte–B–natural killer–dendritic cells’ deficiency successfully treated with hematopoietic stem cell transplantation  Caterina Cancrini,"

Similar presentations

D-dimer: A biomarker for antihistamine-resistant chronic urticaria

D-dimer: A biomarker for antihistamine-resistant chronic urticaria
Immune deficiency caused by impaired expression of nuclear factor-κB essential modifier (NEMO) because of a mutation in the 5′ untranslated region of.

Immune deficiency caused by impaired expression of nuclear factor-κB essential modifier (NEMO) because of a mutation in the 5′ untranslated region of.
Identification of drug- and drug-metabolite immune responses originating from both naive and memory T cells  Andrew Gibson, MRes, Lee Faulkner, PhD, Sally.

Identification of drug- and drug-metabolite immune responses originating from both naive and memory T cells  Andrew Gibson, MRes, Lee Faulkner, PhD, Sally.
Defective B-cell proliferation and maintenance of long-term memory in patients with chronic granulomatous disease  Nicola Cotugno, MD, Andrea Finocchi,

Defective B-cell proliferation and maintenance of long-term memory in patients with chronic granulomatous disease  Nicola Cotugno, MD, Andrea Finocchi,
Plasmacytoid dendritic cell depletion in DOCK8 deficiency: Rescue of severe herpetic infections with IFN-α 2b therapy  Sevgi Keles, MD, Haifa H. Jabara,

Plasmacytoid dendritic cell depletion in DOCK8 deficiency: Rescue of severe herpetic infections with IFN-α 2b therapy  Sevgi Keles, MD, Haifa H. Jabara,
Defective natural killer–cell cytotoxic activity in NFKB2-mutated CVID-like disease  Vassilios Lougaris, MD, Giovanna Tabellini, PhD, Massimiliano Vitali,

Defective natural killer–cell cytotoxic activity in NFKB2-mutated CVID-like disease  Vassilios Lougaris, MD, Giovanna Tabellini, PhD, Massimiliano Vitali,
Combined immunodeficiency due to JAK3 mutation in a child presenting with skin granuloma  Alessia Scarselli, MD, Silvia Di Cesare, BSc, Gigliola Di Matteo,

Combined immunodeficiency due to JAK3 mutation in a child presenting with skin granuloma  Alessia Scarselli, MD, Silvia Di Cesare, BSc, Gigliola Di Matteo,
Defective B-cell proliferation and maintenance of long-term memory in patients with chronic granulomatous disease  Nicola Cotugno, MD, Andrea Finocchi,

Defective B-cell proliferation and maintenance of long-term memory in patients with chronic granulomatous disease  Nicola Cotugno, MD, Andrea Finocchi,
Induction of anergic allergen-specific suppressor T cells using tolerogenic dendritic cells derived from children with allergies to house dust mites 

Induction of anergic allergen-specific suppressor T cells using tolerogenic dendritic cells derived from children with allergies to house dust mites 
B-cell reconstitution after lentiviral vector–mediated gene therapy in patients with Wiskott-Aldrich syndrome  Maria Carmina Castiello, PhD, Samantha.

B-cell reconstitution after lentiviral vector–mediated gene therapy in patients with Wiskott-Aldrich syndrome  Maria Carmina Castiello, PhD, Samantha.
Eosinophilic disorders

Eosinophilic disorders
Timely follow-up of a GATA2 deficiency patient allows successful treatment  Sara Ciullini Mannurita, MSc, Marina Vignoli, PhD, Gloria Colarusso, MD, PhD,

Timely follow-up of a GATA2 deficiency patient allows successful treatment  Sara Ciullini Mannurita, MSc, Marina Vignoli, PhD, Gloria Colarusso, MD, PhD,
Bruton tyrosine kinase mediates TLR9-dependent human dendritic cell activation  Vassilios Lougaris, MD, Manuela Baronio, PhD, Massimiliano Vitali, PhD,

Bruton tyrosine kinase mediates TLR9-dependent human dendritic cell activation  Vassilios Lougaris, MD, Manuela Baronio, PhD, Massimiliano Vitali, PhD,
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization  Silvia.

Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization  Silvia.
In vivo T-cell dynamics during immune reconstitution after hematopoietic stem cell gene therapy in adenosine deaminase severe combined immune deficiency 

In vivo T-cell dynamics during immune reconstitution after hematopoietic stem cell gene therapy in adenosine deaminase severe combined immune deficiency 
Long-term immune reconstitution after matched unrelated hematopoietic stem cell transplantation for immunodeficiency  Vy Hong-Diep Kim, MD, Brenda Reid,

Long-term immune reconstitution after matched unrelated hematopoietic stem cell transplantation for immunodeficiency  Vy Hong-Diep Kim, MD, Brenda Reid,
Is 9 more than 2 also in allergic airway inflammation?

Is 9 more than 2 also in allergic airway inflammation?
Outcomes of patients with severe combined immunodeficiency treated with hematopoietic stem cell transplantation with and without preconditioning  Niraj.

Outcomes of patients with severe combined immunodeficiency treated with hematopoietic stem cell transplantation with and without preconditioning  Niraj.
Advances in basic and clinical immunology in 2011

Advances in basic and clinical immunology in 2011
Expansion of cytotoxic CD56bright natural killer cells during T-cell deficiency after allogeneic hematopoietic stem cell transplantation  Gertjan Lugthart,

Expansion of cytotoxic CD56bright natural killer cells during T-cell deficiency after allogeneic hematopoietic stem cell transplantation  Gertjan Lugthart,

Similar presentations

Ads by Google